Impact of baseline cysts at the time of administration of gonadotropin-releasing hormone analog for in vitro fertilization

被引:0
|
作者
Zeyneloglu, HB
Isik, AZ
Kara, S
Senöz, S
Özcan, U
Gökmen, O
机构
[1] Dr ZT Burak Womens Hosp, Dept Reprod Endocrinol, Ankara, Turkey
[2] Dr ZT Burak Womens Hosp, IVF Unit, Ankara, Turkey
关键词
fertilization in vitro; ovarian cysts; gonadotropin-releasing hormone agonist; ovarian stimulation;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective-To assess the effects of cysts developed prior to the commencement of luteal phase gonadotropin-releasing-hormone-agonist (GnRH-a) in IVF cycles. Design-Retrospective analysis. Setting-In vitro fertilization program in a tertiary hospital infertility clinic. Patients-Women stimulated for IVF-ET. All stimulations were down-regulated with GnRH-a commenced on day 21 in a long protocol before gonadotropin stimulation. Main Outcome Measure-Pregnancy rate. Results-Twenty-five of 121 cycles had cysts >15 mm (20.6%); these were classified as baseline (nonfunctional) (n = 12) or corpus luteum (n = 13) cysts. They had significantly longer suppression periods and lower peak estradiol levels, and used more gonadotropins during stimulation. Cysts had no impact on the number of oocytes collected or fertilization and pregnancy rates. Patients with baseline cysts had a greater duration of suppression and required more gonadotropin than those with corpus luteum cysts or those without cysts. The cycle outcomes were similar between the groups, but baseline cyst formation is likely to increase the cost of IVF. Conclusion-These findings suggest that baseline cyst formation causes longer suppression duration and greater gonadotropin utilization, although an impact on pregnancy rates is unlikely.
引用
收藏
页码:300 / 305
页数:6
相关论文
共 50 条
  • [41] Antimullerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization
    Hamdine, Ouijdane
    Eijkemans, Marinus J. C.
    Lentjes, Eef G. W.
    Torrance, Helen L.
    Macklon, Nick S.
    Fauser, Bart C. J. M.
    Broekmans, Frank J.
    FERTILITY AND STERILITY, 2015, 104 (04) : 891 - +
  • [42] PULSATILE ADMINISTRATION OF GONADOTROPIN-RELEASING HORMONE FOR INDUCTION OF OVULATION
    LOUCOPOULOS, A
    FERIN, M
    VANDEWIELE, RL
    DYRENFURTH, I
    LINKIE, D
    YEH, M
    JEWELEWICZ, R
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 148 (07) : 895 - 900
  • [44] INVITRO FERTILIZATION AND EMBRYO TRANSFER IN PATIENTS WITH ENDOMETRIOSIS - IMPACT OF A GONADOTROPIN-RELEASING HORMONE AGONIST
    OEHNINGER, S
    BRZYSKI, RG
    MUASHER, SJ
    ACOSTA, AA
    JONES, GS
    HUMAN REPRODUCTION, 1989, 4 (05) : 541 - 544
  • [45] Effects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment
    Biljan, MM
    Lapensée, L
    Mahutte, NG
    Bissonnette, F
    Hemmings, R
    Tan, SL
    FERTILITY AND STERILITY, 2000, 74 (05) : 941 - 945
  • [46] The behavior of follicle cysts formed after long-acting gonadotropin-releasing hormone analog administration in patients with polycystic ovarian syndrome
    Ellenbogen, A
    AbuAsbah, I
    Libal, Y
    Jaschevatsky, O
    Anderman, S
    Ballas, S
    GYNECOLOGICAL ENDOCRINOLOGY, 1997, 11 (02) : 101 - 104
  • [47] Negative regulation of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor gene expression by a gonadotropin-releasing hormone agonist in the rat hypothalamus
    Han, YG
    Kang, SS
    Seong, JY
    Geum, D
    Suh, YH
    Kim, K
    JOURNAL OF NEUROENDOCRINOLOGY, 1999, 11 (03) : 195 - 201
  • [48] A GONADOTROPIN-RELEASING HORMONE ANALOG PREVENTS CYCLICAL ATTACKS OF PORPHYRIA
    ANDERSON, KE
    SPITZ, IM
    BARDIN, CW
    KAPPAS, A
    ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (07) : 1469 - 1474
  • [49] DIFFERENTIAL SUPPRESSION OF TESTOSTERONE AND ESTRADIOL WITH A GONADOTROPIN-RELEASING HORMONE ANALOG
    RITTMASTER, RS
    CLINICAL RESEARCH, 1988, 36 (03): : A389 - A389
  • [50] Gonadotropin-Releasing Hormone Analog Cotreatment for Preservation of Ovarian Function
    Blumenfeld, Zeev
    ONCOLOGIST, 2012, 17 (02): : 162 - 163